Genomictree Inc. Cash Flow Reinvestment Rate
Genomictree Inc. cash flow reinvestment rate. Genomictree Inc. (228760) has a Cash Flow Reinvestment Rate of 3.71x as of December 2022, reinvesting ₩15.89 Billion (capex ₩1.82 Billion plus investments ₩14.07 Billion) from operating cash flow of ₩4.29 Billion. Explore cash flow to debt ratio of Genomictree Inc. to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Genomictree Inc. (2022–2022)
Cash flow reinvestment rate of Genomictree Inc. from 2022 to 2022. Historical reinvestment intensity for Genomictree Inc. across 1 annual periods. Explore 228760 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Genomictree Inc. Cash Flow Reinvestment Rate by Year (2022–2022)
Genomictree Inc. cash flow reinvestment rate by year from 2022 to 2022. Year-by-year capital reinvestment analysis for Genomictree Inc.. For the full cash flow conversion analysis, see 228760 cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 3.71x | ₩15.89 Billion | ₩4.29 Billion | ₩1.82 Billion | — |